HONG KONG, November 20, 2018 /PRNewswire/ --
Alma, one of the top five global leaders of energy-based medical andaesthetic solutions, today announced it has completed the first step of acquiring its Israeli distributor Nova Medical, extending its business outreach and establishing a direct operation in Israel.
Upon completion of the acquisition, Alma will hold a 60% stake in Nova Medical. The acquisition is part of Alma's Direct-to-Consumer strategy, outlined in 2017, aimed at maintaining Alma's leading position in the market and strengthening its brand awareness among consumers.
"We are delighted to share the news regarding Nova Medical acquisition. Our long-term successful business relationship, Nova's strong market position in Israel and recent success in launching new products domains, such as injectables, ensures the future success of our direct operation in Israel," said Lior Dayan, Alma's CEO.
Alma is a global innovator of Laser, Light-based, Radiofrequency, Plasma and Ultrasound solutions for the aesthetic and surgical markets. We enable practitioners to offer safe and effective procedures while allowing patients to benefit from state-of-the-art, clinically proven technologies and treatments.
About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK), the first Israeli company to be listed on the Hong Kong Exchange Main Board, was established in 2013 for the acquisition of Alma, a leading provider of energy-based surgical and medical aesthetic solutions, ranked No. 1 in the People's Republic of China and one of the top 5 global leaders in its industry. Sisram Medical is majority held by Fosun Pharma, a leading healthcare group in China.
Sisram Medical - Enhancing Quality of Life.
For media inquiries, please contact: Sivan Raz Tel: +972-54-2630020 E-mail: Sivan.firstname.lastname@example.org
SOURCE Alma Lasers
Subscribe to our Free Newsletters!